TP53 and urinary bladder cancer: Mutations in the p53 gene are the most common genetic defect in human bladder cancer, which occur in approximately 50% of bladder cancer and are associated with high-stage, high-grade TCC (Sidransky et al, 1991; Esrig et al, 1994).